rg3 脑瘤 抗血管生成
INTERNATIONAL JOURNAL OF ONCOLOGY 41: 1669-1674, 2012
Chronic treatment with ginsenoside Rg3 induces Akt-dependent senescence in human glioma cells
SEONG SIN1,2*, SUNG YOUNG KIM2* and SUNG SU KIM1,2
1
Department of Oriental Medicine, Kyung Hee University College of Oriental Medicine, Seoul 130-701;
2
Soram Cancer and Immunotherapy Research Center, Seoul 135-090, Republic of Korea
Received April 6, 2012; Accepted June 14, 2012
DOI: 10.3892/ijo.2012.1604
Abstract. Therapy-induced senescence, an irreversible growth arrest, in cancer cells is regarded as a novel functional target that may improve cancer therapy. 20(S)-ginsenoside Rg3 [20(S)-Rg3], a chemical component extracted from Panax ginseng, has recently emerged as an effective anticancer medicine with evident antitumor effects and no observed toxic adverse reactions. We report here that chronic treat-ment with 20(S)-Rg3 in a sub-lethal concentration induced senescence-like growth arrest in human glioma cells. Glioma cells treated with 20(S)-Rg3 showed high expression of senes-cence-associated β-galactosidase, followed by upregulation of the CDK inhibitors p21 and p16. Moreover, reactive oxygen species (ROS) generation markedly increased in 20(S)-Rg3-treated cells compared with control cells. Consistently, co-incubation with the antioxidant N-acetyl cysteine inter-fered with 20(S)-Rg3-induced senescence in glioma cells. In addition, 20(S)-Rg3-induced-activation of Akt was associated with increased ROS levels, and depletion of Akt partially prevented 20(S)-Rg3-induced ROS generation and senescence induction in glioma cells. Furthermore, 20(S)-Rg3-induced senescence was partially rescued when the p53/p21 pathway was inactivated. Our data indicate that 20(S)-Rg3 induces senescence-like growth arrest in human glioma cancer through the Akt and p53/p21-dependent signaling pathways. This is the first report of a pro-senescent effect of 20(S)-Rg3 in cancer cells. Introduction
It is widely accepted that normal somatic cells have intrinsi-cally limited division capacity and reach a non-proliferative
Correspondence to: Professor Sung Su Kim, Soram Cancer and
Immunotherapy Research Center, Samsungdong, Kangnamgu, Seoul, Republic of Korea
E-mail: ssukim12@gmail.com
*
state called cellular senescence. Senescent cells are character-ized by irreversible growth arrest, a typical gene-expression profile, hyporesponsiveness to external stimuli, increased acidic β-galactosidase activity, and a at and enlarged morphology. Most tumors contain cell populations that have escaped the senescence barriers to proliferative potential. This capability, known as immortality, could trigger genomic insta-bility and tumorigenesis. Therefore, cellular senescence has been proposed as a major tumor suppression mechanism (1), and therapy-induced senescence represents a novel functional target that may improve cancer therapy (2-5).
Gliomas are the most common primary brain tumor in adults, and high-grade gliomas are almost universally fatal. Despite recent advances in diagnosis and therapy, including surgical resection followed by radiation and chemotherapy, the prognosis for patients with malignant glioma remain unsatisfactory due to the high recurrence rate and relative drug resistance of high-grade glioma cells (6). Conventional anticancer drugs are associated with relatively strong toxic side-effects and drug resistance.
20(S)-ginsenoside Rg3 [20(S)-Rg3] is an effective medicinal chemical compound extracted from Panax ginseng with a C42H72O13 framework and 784.3 Da molecular weight (7). 20(S)-Rg3 has been shown to be safe, and recent evidence from in vitro experiments and animal models have demon-strated that 20(S)-Rg3 possesses a variety of anti-mutagenic and cancer-inhibitory properties (8-12). However, the exact molecular mechanism of its antitumor effects remains unclear.Here, we show that chronic treatment with 20(S)-Rg3 at a sub-apoptotic concentration caused senescence-like growth arrest in U87 glioma cells and that this was partially reliant on 20(S)-Rg3-induced ROS generation and induction of p53/p21. Moreover, we found that Akt plays a critical role in 20(S)-Rg3-induced ROS generation and senescence in glioma cells.
Materials and methods
Materials. U87 glioma cell lines were purchased from American Type Culture Collections (Manassas, VA, USA). These cell lines were cultured in Dulbecco's modified Eagle's medium (HyClone, Logan, UT, USA) supplemented with 10% fetal bovine serum and 25 U/ml penicillin/streptomycin. Anti-phospho-p53, and phospho-Akt polyclonal antibody were
Contributed equally
Key words: ginsenoside Rg3, senescence, glioma, Akt, ROS
Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence 隐藏>> NIH Public Access Author Manuscript Aging Cell. Author manusc...
Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence 隐藏>> NIH Public Access Author Manuscript Aging Cell. Author manusc...
热门文档